

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100/50mcg | 3 inhalers | NZD331.60 | NZD994.78 Best Price | |
| 100/50mcg | 2 inhalers | NZD343.77 | NZD687.51 | |
| 100/50mcg | inhaler | NZD410.67 | NZD410.67 | |
| 250/50mcg | 3 inhalers | NZD356.94 | NZD1,070.83 | |
| 250/50mcg | 2 inhalers | NZD412.22 | NZD824.41 | |
| 250/50mcg | inhaler | NZD465.43 | NZD465.43 | |
| 500/50mcg | 3 inhalers | NZD439.08 | NZD1,317.25 Popular | |
| 500/50mcg | 2 inhalers | NZD480.67 | NZD961.31 | |
| 500/50mcg | inhaler | NZD520.19 | NZD520.19 |
Advair Diskus is an inhaled medicine that combines two active ingredients: fluticasone propionate and salmeterol xinafoate. It is intended for regular, long-term use to help control breathing problems in asthma and chronic obstructive pulmonary disease (COPD). The medicine is delivered as a dry powder inhalation in a single device.
The two components work together: fluticasone reduces inflammation in the airways, while salmeterol helps keep the airway muscles relaxed for a longer period. This combination is designed to lower the frequency of symptoms and reduce the need for urgent rescue medicines when used as directed by a healthcare professional. In New Zealand, Advair Diskus may require a prescription depending on local rules.
Advair Diskus is supplied in a device that holds a fixed number of doses. Each actuation delivers a measured amount of powder to be inhaled. The device has a mouthpiece and a cap; it should be kept closed when not in use to protect the powder from moisture.
It is important to use Advair Diskus exactly as prescribed by a healthcare professional. Do not change the dose or stop using the inhaler without advice. It is not intended to relieve sudden breathing problems and should not be used as a rescue inhaler during an acute attack.
Before starting Advair Diskus, tell your healthcare provider about any allergies, current medications, and health conditions. Your doctor can explain how this inhaler fits into your overall treatment plan and how to monitor its effects over time.
Advair Diskus is used for long-term control of asthma in eligible patients and for maintenance treatment of COPD in adults. It is designed to be used regularly, not just when symptoms occur. The medicine is not a fast-acting reliever for sudden breathing problems.
It is typically prescribed as part of a broader management plan that may include avoiding triggers, regular monitoring, and other medicines. The goal is to reduce symptoms, improve breathing, and lower the risk of exercise limitation and nighttime awakenings due to breathing problems.
Advair Diskus may be prescribed when a healthcare professional determines that a combination of anti-inflammatory and airway-relaxing treatment is appropriate. The choice depends on the individual’s pattern of symptoms, lung function, and response to other therapies. Always follow the prescribed plan and discuss any concerns with your clinician.
The medicine may require a prescription depending on local regulations. Always keep follow-up appointments to review effectiveness and any side effects. If you have not noticed improvement after a coordinated period of use, contact your doctor for advice.
In New Zealand, health professionals assess the appropriateness of Advair Diskus within a patient’s overall asthma or COPD management plan. Do not change or stop therapy without consulting a clinician, as this could affect breathing control and disease progression.
The active components in Advair Diskus work in two complementary ways. Fluticasone propionate is a corticosteroid that reduces inflammation in the airways, helping to prevent swelling that can narrow the passages you breathe through. This can lead to fewer symptoms over time with consistent use.
Salmeterol xinafoate is a long-acting beta-agonist (LABA) that relaxes the muscles in the airways. By keeping the airways open for longer periods, it helps prevent breathing problems during the day and night and reduces the need for rescue medications.
Because this is a maintenance inhaler, it is intended for ongoing control rather than immediate relief. Some people notice gradual improvement over days to weeks, while others may respond more slowly. If there is no improvement or symptoms worsen, a healthcare professional should reassess the treatment plan.
Advair Diskus is designed to deliver a consistent dose with each use. The combination approach aims to improve overall lung function and quality of life when used as directed and as part of a broader disease-management strategy. Individuals should be monitored regularly for effectiveness and potential side effects.
People should be aware that the inhaler provides a steady anti-inflammatory and bronchodilator effect, and it does not cure the underlying condition. Ongoing medical supervision helps ensure the therapy remains appropriate as symptoms change over time.
Advair Diskus is a dry powder inhaler. Proper technique is important to ensure the dose is inhaled effectively. Read the patient information provided with the inhaler and ask a pharmacist or clinician if anything is unclear. A healthcare professional can demonstrate the correct method and allow practice with supervision.
Prepare the device according to the instructions, and then inhale a dose with a deep, fast breath through the mouthpiece. Do not breathe out into the mouthpiece, and avoid blocking the opening with your tongue or teeth. After inhaling, hold the breath for a short moment to maximise delivery before exhaling gently.
After each use, close the device by replacing the cap and store it in a dry place. Do not wash the inhaler or expose it to moisture. Do not attempt to remove the powder or alter the device; any damage can affect the amount delivered per dose.
Do not share the inhaler with others, and keep it out of the reach of children. If a dose is missed, follow the guidance provided by your clinician or the leaflet, and do not double the dose to catch up. If you have any concerns about missed doses, contact a healthcare professional for advice.
Rinse your mouth with water after using Advair Diskus to help reduce the chance of mouth or throat irritation and oral infections. Do not swallow the powder; ensure it is inhaled through the mouthpiece with a full, steady breath. If you notice any changes in taste or persistent irritation, consult a clinician promptly.
Advair Diskus may not be suitable for everyone. Individuals with a history of certain allergic reactions to the ingredients should discuss alternative options with a healthcare professional. Some people may experience sensitivity to lactose or other components in the inhaler.
People with a recent history of a severe asthma attack requiring urgent medical care should be evaluated before using a maintenance inhaler like Advair Diskus. Infections of the airways or a significant pulmonary infection may require different management until the infection resolves.
If you have a condition such as severe or untreated infections, high blood pressure, heart rhythm problems, or certain eye problems like glaucoma, speak with a clinician about the potential risks and benefits. Advair Diskus is not a rescue therapy during an acute breathing episode and may interact with other medicines; always disclose all current medicines to your healthcare provider.
Pregnant or breastfeeding people should seek medical advice before starting this inhaler. The safety of Advair Diskus in pregnancy or during breastfeeding has not been established in all situations, and a clinician can help assess the best option. Do not start or continue therapy without professional guidance.
In New Zealand, Advair Diskus may be prescribed based on individual health needs and local rules. Always confirm whether this medicine is appropriate for your situation with a doctor or pharmacist before starting therapy.
Advair Diskus can cause side effects and may not be suitable for everyone. Tell your clinician about all other illnesses, especially mucus infections, diabetes, osteoporosis, an untreated fungal infection of the mouth, or a history of severe allergic reactions. These factors can influence the safety and effectiveness of the treatment.
Do not use Advair Diskus to treat a sudden asthma attack or a severe COPD flare. Keep a fast-acting rescue inhaler on hand as advised by your healthcare provider. If symptoms worsen or do not improve after starting treatment, seek medical attention promptly.
Regular monitoring by a clinician is important. Report any signs of infection, vision changes, excessive thirst or urination, bone thinning, or unusual mood or behavior. If you notice swelling, numbness or tingling in the legs or feet, speak with a clinician to assess the risk of systemic effects.
Inhaled corticosteroids like fluticasone can increase the risk of thrush in the mouth or throat. Rinse your mouth after each use and monitor for white patches or soreness. If thrush develops, a clinician may prescribe a topical treatment or adjust the regimen.
Consider potential interactions with other medicines, including over-the-counter remedies, supplements, or other inhaled products. Always discuss all medicines with a healthcare professional to minimize risks and ensure compatibility. Seek urgent medical help if you experience severe allergic symptoms or signs of a serious reaction after using this inhaler.
Like many medicines, Advair Diskus can cause side effects. The most common ones include throat irritation, hoarseness, and coughing after inhalation. Some people also report headaches or a runny or stuffy nose.
Oral thrush (a white patch in the mouth or throat) may occur due to the corticosteroid component. Mouth rinsing after use can help reduce this risk. If thrush develops, tell your clinician; a different approach or additional treatments may be considered.
Other possible effects include dizziness, tremor, or increased heart rate. If these symptoms persist or become bothersome, contact a healthcare professional for advice. Seek medical attention if you notice swelling of the face, lips, tongue, or throat, or any signs of a severe allergic reaction.
More rarely, people may experience vision changes, bone thinning with long-term use, or changes in blood sugar levels. Discuss any concerns about long-term use with your clinician, especially if there are pre-existing conditions that could be affected.
As with any inhaled therapy, some individuals may have sensitivity to the medication. If you notice persistent or unusual symptoms after using Advair Diskus, contact a healthcare professional to evaluate the situation and adjust treatment if needed.
Tell your healthcare provider about all medicines you take, including prescription, over-the-counter medicines, and supplements. Some drugs can affect how Advair Diskus works or increase the risk of side effects. Examples include certain medicines used to treat heart rhythm problems, infections, or high blood pressure.
Beta-blockers, certain antifungal agents, and some antibiotics are examples that may interact with inhaled therapies. Your clinician can assess potential interactions and decide if adjustments are needed. Do not start or stop any medicine without professional advice.
If you are using other inhaled medicines, share information about the timing and doses with your clinician. Combining inhaled therapies without medical supervision can lead to reduced effectiveness or increased side effects. A healthcare professional can help coordinate a safe and effective plan.
Herbal or natural products may also interact in unexpected ways. It is important to discuss anything you are taking, even if it seems unrelated to breathing, to avoid unintended effects. Regular check-ins with your clinician help ensure the treatment remains appropriate.
In New Zealand, the safety of combining Advair Diskus with other medicines should be reviewed in the context of local guidelines and the patient’s medical history. Always disclose all current treatments during appointments to support safe decision-making.
In pregnancy, the potential benefits and risks of continuing Advair Diskus should be discussed with a clinician. The available information may not cover every situation, so individual assessment is important. Do not start or stop treatment during pregnancy without medical guidance.
Breastfeeding during treatment should be discussed with a healthcare professional. The medicine can pass into breast milk, and a clinician can advise on whether to continue, adjust, or pause therapy depending on the circumstances. The decision will consider the health needs of both mother and baby.
If pregnancy is planned, or if there is a chance of pregnancy, seek advice about alternatives or adjustments before starting or continuing Advair Diskus. The goal is to balance effective disease control with safety for the mother and baby.
Patients should inform their clinician if they are pregnant, planning pregnancy, or breastfeeding at any time during therapy. Ongoing communication helps ensure appropriate care and monitoring. A pharmacist can also provide guidance on available options and local regulations in New Zealand.
Always follow professional guidance on use during pregnancy or breastfeeding rather than relying on general information. Check the official leaflets and discuss any concerns with a healthcare professional if you are unsure.
Advair Diskus is intended for long-term, ongoing control of breathing problems. Some people may notice gradual improvement over days to weeks, while others may take longer. The exact timeline can vary based on individual factors and adherence to the treatment plan.
If symptoms persist or worsen after a reasonable period, discuss this with your clinician. They can review the regimen and offer guidance on next steps or alternative treatments. Do not expect immediate relief from a maintenance inhaler.
No. Advair Diskus is a maintenance inhaler, not a rescue inhaler. It is designed for ongoing control and should be used as prescribed to reduce symptoms over time. For acute breathing problems, a fast-acting rescue inhaler recommended by your clinician should be used.
Keep a rescue inhaler available as part of your asthma or COPD management plan, and use it as directed when symptoms flare. If you rely on rescue inhalers more often, contact your healthcare professional for advice.
If you miss a scheduled dose, take it as soon as you remember, unless it is almost time for your next dose. Do not double the dose to catch up. If you are unsure what to do, contact your clinician for personalized guidance.
Consistency is important for maintenance therapy. If you frequently miss doses, discuss strategies with your pharmacist or clinician to improve adherence and maintain symptom control.
Switching from another inhaler should be done under medical supervision. A clinician can determine whether Advair Diskus is appropriate and provide instructions on how to transition safely. They may adjust dose timing, technique, and monitoring to ensure a smooth change.
Follow the prescribed plan and attend follow-up visits to assess effectiveness and tolerability after a switch. Do not change devices or regimens on your own.
In general, Advair Diskus is used without spacers. If you are prescribed multiple inhalers, your clinician will provide specific instructions on the order of use and spacing between inhalations. Spacers are more commonly used with certain inhalers, but not all devices are compatible with spacers.
Always use each inhaler as directed and avoid altering the devices without professional advice. If you have questions about combining inhalers, ask your pharmacist for a demonstration and a written plan.
Common side effects include throat irritation, hoarseness, and cough after inhaling. Mouth rinsing after use can help reduce the risk of mouth ulcers or thrush. If symptoms persist or cause concern, contact a healthcare professional for advice.
Headache or nasal symptoms may occur from time to time. If you notice persistent or severe side effects, discuss them with your clinician promptly. They can assess whether the therapy remains appropriate for you.
Yes. Rinsing your mouth with water after each use helps reduce the chance of mouth and throat irritation and thrush. Do not swallow the rinse water. Spit it out and continue with your normal routine.
If thrush develops, your clinician may suggest antifungal treatment or a small adjustment to your regimen. Maintaining good oral hygiene is helpful during maintenance inhaler therapy.
Contact your clinician if you notice a significant worsening of breathing, an attack despite using the rescue inhaler, or signs of an allergic reaction such as swelling of the face or lips, severe rash, or trouble breathing. Seek urgent medical help if breathing becomes severely difficult or if there are signs of a medical emergency.
You should also talk to a clinician if you experience persistent side effects, eye changes, or new symptoms that could indicate another condition. Regular follow-up appointments are important to ensure the treatment remains appropriate.
Do not stop using Advair Diskus abruptly without medical advice. Stopping abruptly can cause a loss of disease control. If discontinuation is considered, your clinician will plan a safe transition and monitor your breathing during the change.
Discuss any concerns about stopping or reducing the dose with a healthcare professional. They may propose an alternative treatment or a tapering strategy as part of a guided plan.
The safety of Advair Diskus during pregnancy and breastfeeding should be discussed with a clinician. The decision depends on the balance of potential benefits to the mother and possible risks to the baby. Do not start or stop therapy without professional advice.
Breastfeeding while using Advair Diskus should be discussed with a clinician, who can provide guidance based on the individual situation. If alternatives are available, the clinician may recommend the option with the best overall outcome for the infant and mother.
Store Advair Diskus in a dry place at room temperature and away from moisture or heat. Keep the device capped when not in use. Disposal guidelines may vary by location, so check locally with your pharmacist or clinician for safe disposal practices.
Do not attempt to reuse an empty dose cartridge or keep a broken device. If you have questions about disposal, ask a pharmacist for instructions that align with New Zealand regulations and supplier guidance.
14–21 days. Free from NZD339.16 .
5–9 days. NZD50.87
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.